EVIDENCE SYNTHESIS OF ASSOCIATION OF HLA-B*1502 ALLELE AND CARBAMAZEPINE -INDUCED STEVENS JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS: A SYSTEMATIC REVIEW

被引：0
|
作者：
Tangamornsuksan, W. [1 ]
Chaiyakunapruk, N. [1 ]
Somkrua, R. [2 ]
Lohitnavy, M. [3 ]
Tassaneeyakul, W. [4 ]
机构：
[1] Ctr Pharmaceut Outcomes Res, Muang, Phitsanulok, Thailand
[2] Kasemrad Sriburin Hosp, Muang, Chiangrai, Thailand
[3] Ctr Excellence Environm Hlth & Toxicol, Muang, Phitsanulok, Thailand
[4] Res & Diagnost Ctr Emerging Infect Dis, Khon Kaen, Thailand
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.225
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A640 / A640
页数：1
相关论文
共 50 条
  • [21] HLA-B*1502 Genotyping in Carbamazepine and Phenytoin Induced Stevens-Johnson Syndrome
    Rajappa, Sivakumar M.
    Venkatesan, Srinivasan A.
    [J]. ANNALS OF NEUROLOGY, 2011, 70 : S83 - S83
  • [22] HLA-B sequencing in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
    Lenz, Brittany
    Patterson, Andrew
    Laska, Amanda
    Brown, Patrick
    Beachkofsky, Thomas
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB156 - AB156
  • [23] HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
    Kaniwa, Nahoko
    Saito, Yoshiro
    Aihara, Michiko
    Matsunaga, Kayoko
    Tohkin, Masahiro
    Kurose, Kouichi
    Furuya, Hirokazu
    Takahashi, Yukitoshi
    Muramatsu, Masaaki
    Kinoshita, Shigeru
    Abe, Masamichi
    Ikeda, Hiroko
    Kashiwagi, Mariko
    Song, Yixuan
    Ueta, Mayumi
    Sotozono, Chie
    Ikezawa, Zenro
    Hasegawa, Ryuichi
    [J]. EPILEPSIA, 2010, 51 (12) : 2461 - 2465
  • [24] Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis
    Wimonchat Tangamornsuksan
    Manupat Lohitnavy
    [J]. The Pharmacogenomics Journal, 2019, 19 : 286 - 294
  • [25] Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis
    Tangamornsuksan, Wimonchat
    Lohitnavy, Manupat
    [J]. PHARMACOGENOMICS JOURNAL, 2019, 19 (03): : 286 - 294
  • [26] HLA-A*31:01 and HLA-B*15:02 association with Stevens-Johnson syndrome and toxic epidermal necrolysis to carbamazepine in a multiethnic Malaysian population
    Khor, Amy Hui-Ping
    Lim, Kheng-Seang
    Tan, Chong-Tin
    Kwan, Zhenli
    Tan, Wooi-Chiang
    Wu, David Bin-Chia
    Ng, Ching-Ching
    [J]. PHARMACOGENETICS AND GENOMICS, 2017, 27 (07): : 275 - 278
  • [27] Carbamazepine: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    不详
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2012, 16 (05) : 326 - 327
  • [28] HLA-B*1502 is associated with carbamazepine induced Stevens-Johnson syndrome in North Indian population
    Aggarwal, Ritu
    Sharma, Madhulika
    Modi, Manish
    Garg, Vivek Kumar
    Salaria, Manilla
    [J]. HUMAN IMMUNOLOGY, 2014, 75 (11) : 1120 - 1122
  • [29] Structural modeling of HLA-B*1502/peptide/carbamazepine/T-cell receptor complex architecture: implication for the molecular mechanism of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis
    Zhou, Peng
    Zhang, Shilei
    Wang, Yewang
    Yang, Chao
    Huang, Jian
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2016, 34 (08): : 1806 - 1817
  • [30] HLA B*1502 as a Genetic Marker for Carbamazepine Induced Stevens Johnson Syndrome
    Rajappa, Sivakumar M.
    Venkatesan, Srinivasan A.
    [J]. NEUROLOGY, 2010, 74 (09) : A305 - A305
12345